Back to calendar
Spero Therapeutics, Inc. (SPRO) Earnings
SPRO reports earnings on Monday, November 16, 2026
earnings report
November 16, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.47
Actual EPS: $-0.16
Company overview
Market Cap$61.7M
SectorHealth Technology
IndustryBiotechnology